Home LiteratureArticle Details
PMID: 8388478 Published · ppublish English Journal Article

Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.

Journal of the National Cancer Institute ·Vol. 85 ·No. 12 ·1993-06-16 ·Pages 958-64

Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott DR, Sherman ME, Kurman RJ, Wacholder S

Abstract

Experimental studies have provided strong evidence that human papillomavirus (HPV) is the long-sought venereal cause of cervical neoplasia, but the epidemiologic evidence has been inconsistent. Given improvements in HPV testing that have revealed a strong link between sexual activity history and cervical HPV infection, we conducted a large case-control study of HPV and cervical intraepithelial neoplasia (CIN) to evaluate whether sexual behavior and the other established risk factors for CIN influence risk primarily via HPV infection. We studied 500 women with CIN and 500 control subjects receiving cytologic screening at Kaiser Permanente, a large prepaid health plan, in Portland, Ore. The established epidemiologic risk factors for CIN were assessed by telephone interview. We performed HPV testing of cervicovaginal lavage specimens by gene amplification using polymerase chain reaction with a consensus primer to target the L1 gene region of HPV. Unconditional logistic regression analysis was used to estimate relative risk of CIN and to adjust the epidemiologic associations for HPV test results to demonstrate whether the associations were mediated by HPV. The case subjects demonstrated the typical epidemiologic profile of CIN: They had more sex partners, more cigarette smoking, earlier ages at first sexual intercourse, and lower socioeconomic status. Statistical adjustment for HPV infection substantially reduced the size of each of these case-control differences. Seventy-six percent of cases could be attributed to HPV infection; the results of cytologic review suggested that the true percentage was even higher. Once HPV infection was taken into account, an association of parity with risk of CIN was observed in both HPV-negative and HPV-positive women. The data show that the great majority of all grades of CIN can be attributed to HPV infection, particularly with the cancer-associated types of HPV. In light of this conclusion, the investigation of the natural history of HPV has preventive as well as etiologic importance.

Keywords
Americas Biology Cancer Case Control Studies Cervical Cancer Developed Countries Diseases Epidemiology Health Hpv Neoplasms North America Northern America Oregon Public Health Research Methodology Research Report Risk Factors Studies United States Viral Diseases
MeSH Terms
Adolescent Adult Age Factors Carcinoma in Situ/epidemiology,microbiology Case-Control Studies Coitus Contraceptives, Oral DNA Probes, HPV Educational Status Female Humans Income Logistic Models Middle Aged Oregon/epidemiology Papillomaviridae/genetics,pathogenicity Parity Risk Factors Sexual Partners Smoking Tumor Virus Infections/epidemiology,microbiology Uterine Cervical Dysplasia/microbiology Uterine Cervical Neoplasms/epidemiology,microbiology
Chemicals
Contraceptives, Oral DNA Probes, HPV
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Schiffman M H
Epidemiology and Biostatistics Program, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Bauer H M
Hoover R N
Glass A G
Cadell D M
Rush B B
Scott D R
Sherman M E
Kurman R J
Wacholder S
Article Info
Journal
Journal of the National Cancer Institute
Abbr.
J Natl Cancer Inst
ISSN
0027-8874
Published
1993-06-16
Pages
958-64
Language
English
Region
United States
NLM ID
7503089
Subset
IM
Corrections
CommentIn
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com